The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preclinical evaluation of 99mtechnetium-HYNIC(tricine/TPPTS)-aca-bombesin(7-14) as a targeted imaging agent in prostate cancer.
Hildo J. K. Ananias
No relevant relationships to disclose
Zilin Yu
No relevant relationships to disclose
Philip H. Elsinga
No relevant relationships to disclose
Igle J. de Jong
No relevant relationships to disclose